The Apolipoprotein A5 -1131T>C Promoter Polymorphism in Koreans: Association with Plasma APOA5 and Serum Triglyceride Concentrations, LDL Particle Size and Coronary Artery Disease

Overview

Journal Clin Chim Acta

Specialty Biochemistry

Date 2009 Jan 23

PMID 19159622

Citations 23

Authors

Yangsoo Jang

Jean Kyung Paik

Yae Jung Hyun

Jey Sook Chae

Ji Young Kim

Ju Ree Choi

Sang Hak Lee

Dong-Jik Shin

Jose M Ordovas

Jong Ho Lee

Affiliations

Soon will be listed here.

Abstract

Background: The association between -1131T>C single nucleotide polymorphism (SNP) of the apolipoprotein A5 gene (APOA5) and hypertriglyceridemia raised the possibility that this SNP could be related to coronary artery disease (CAD) risk. Therefore, we investigated the association of this APOA5 -1131T>C SNP with circulating concentrations of APOA5, triglyceride and CAD in Koreans.

Methods: CAD patients (n=741) and age-, sex-matched healthy controls (n=741) were genotyped for the APOA5 -1131T>C SNP. The main outcome measures were the odds ratio (OR) on CAD risk and lipid variables, APOA5 concentration and LDL particle size.

Results: The presence of the minor allele at the -1131T>C SNP was associated with an increased risk of CAD [OR 1.34 (95% CI, 1.09-1.65), P=0.007] after adjusting for BMI, alcohol consumption, systolic blood pressure and diastolic blood pressure. There was an association between the APOA5 concentration and the -1131T>C genotype in controls (T/T: 245+/-7 ng/ml, T/C: 220+/-6, C/C: 195+/-12; P=0.001) and CAD patients (T/T: 218+/-8 ng/ml, T/C: 185+/-7, C/C: 169+/-12; P<0.001). Subjects with T/C or C/C in control and CAD patient groups showed higher triglyceride than those with T/T genotype. Also, the -1131T>C polymorphism was associated with LDL particle size (P=0.003), with the T/C or C/C controls having smaller size than the T/T controls.

Conclusions: The APOA5 -1131C allele is associated with reduced APOA5 concentration and with increased CAD risk. This is consistent with the observed association between the -1131C SNP, increased triglycerides as well as small LDL particle size.

Citing Articles

The Biology and Clinical Implications of PCSK7.

Sachan V, Susan-Resiga D, Lam K, Seidah N Endocr Rev. 2024; 46(2):281-299.

PMID: 39661471 PMC: 11894536. DOI: 10.1210/endrev/bnae031.

Association between APOA5 polymorphisms and susceptibility to metabolic syndrome: a systematic review and meta-analysis.

Mozafari S, Ashoori M, Meybodi S, Solhi R, Reza Mirjalili S, Dehghani Firoozabadi A BMC Genomics. 2024; 25(1):590.

PMID: 38867151 PMC: 11167842. DOI: 10.1186/s12864-024-10493-x.

Effects of polymorphisms in APOA5 on the plasma levels of triglycerides and risk of coronary heart disease in Jilin, northeast China: a case-control study.

You Y, Wu Y, Zhang Y, Zhang L, Song Y, Bai W BMJ Open. 2018; 8(6):e020016.

PMID: 29866721 PMC: 5988145. DOI: 10.1136/bmjopen-2017-020016.

A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients.

Kim M, Kim M, Yoo H, Lee E, Chae J, Lee S PLoS One. 2017; 12(12):e0186693.

PMID: 29211729 PMC: 5718602. DOI: 10.1371/journal.pone.0186693.

The APOA5 rs662799 polymorphism is associated with dyslipidemia and the severity of coronary heart disease in Chinese women.

Wang Y, Lu Z, Zhang J, Yang Y, Shen J, Zhang X Lipids Health Dis. 2016; 15(1):170.

PMID: 27716220 PMC: 5054624. DOI: 10.1186/s12944-016-0343-z.

References

Szalai C, Keszei M, Duba J, Prohaszka Z, Kozma G, Csaszar A . Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis. 2004; 173(1):109-14. DOI: 10.1016/j.atherosclerosis.2003.12.003. View

van der Vliet H, Schaap F, Levels J, Ottenhoff R, Looije N, Wesseling J . Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice. Biochem Biophys Res Commun. 2002; 295(5):1156-9. DOI: 10.1016/s0006-291x(02)00808-2. View

Pennacchio L, Olivier M, Hubacek J, Cohen J, Cox D, Fruchart J . An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001; 294(5540):169-73. DOI: 10.1126/science.1064852. View

Grosskopf I, Baroukh N, Lee S, Kamari Y, Harats D, Rubin E . Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants. Arterioscler Thromb Vasc Biol. 2005; 25(12):2573-9. DOI: 10.1161/01.ATV.0000186189.26141.12. View

Talmud P, Hawe E, Miller G, Humphries S . Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men. Arterioscler Thromb Vasc Biol. 2002; 22(11):1918-23. DOI: 10.1161/01.atv.0000035521.22199.c7. View

Cullen P . Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol. 2000; 86(9):943-9. DOI: 10.1016/s0002-9149(00)01127-9. View

Jang Y, Kim J, Kim O, Lee J, Cho H, Ordovas J . The -1131T-->C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men. Am J Clin Nutr. 2004; 80(4):832-40. DOI: 10.1093/ajcn/80.4.832. View

Pennacchio L, Olivier M, Hubacek J, Krauss R, Rubin E, Cohen J . Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet. 2002; 11(24):3031-8. DOI: 10.1093/hmg/11.24.3031. View

Lai C, Demissie S, Cupples L, Zhu Y, Adiconis X, Parnell L . Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. J Lipid Res. 2004; 45(11):2096-105. DOI: 10.1194/jlr.M400192-JLR200. View

10.

Jeppesen J, Hein H, Suadicani P, Gyntelberg F . Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation. 1998; 97(11):1029-36. DOI: 10.1161/01.cir.97.11.1029. View

11.

Nabika T, Nasreen S, Kobayashi S, Masuda J . The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese. Atherosclerosis. 2002; 165(2):201-4. DOI: 10.1016/s0021-9150(02)00252-6. View

12.

Hsu L, Ko Y, Chang C, Hu C, Wu S, Teng M . Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis. 2005; 185(1):143-9. DOI: 10.1016/j.atherosclerosis.2005.05.031. View

13.

Horinek A, Vrablik M, Ceska R, Adamkova V, Poledne R, Hubacek J . T-1131-->C polymorphism within the apolipoprotein AV gene in hypertriglyceridemic individuals. Atherosclerosis. 2003; 167(2):369-70. DOI: 10.1016/s0021-9150(03)00022-4. View

14.

Talmud P, Martin S, Taskinen M, Frick M, Nieminen M, Kesaniemi Y . APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study. J Lipid Res. 2004; 45(4):750-6. DOI: 10.1194/jlr.M300458-JLR200. View

15.

van der Vliet H, Sammels M, Leegwater A, Levels J, Reitsma P, Boers W . Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem. 2001; 276(48):44512-20. DOI: 10.1074/jbc.M106888200. View

16.

Wong W, Hawe E, Li L, Miller G, Nicaud V, Pennacchio L . Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels. Circ Res. 2003; 92(9):969-75. DOI: 10.1161/01.RES.0000069688.94567.7A. View

17.

Schaap F, Rensen P, Voshol P, Vrins C, van der Vliet H, Chamuleau R . ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J Biol Chem. 2004; 279(27):27941-7. DOI: 10.1074/jbc.M403240200. View

18.

Endo K, Yanagi H, Araki J, Hirano C, Yamakawa-Kobayashi K, Tomura S . Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren. Hum Genet. 2002; 111(6):570-2. DOI: 10.1007/s00439-002-0825-0. View

19.

Evans D, Buchwald A, Beil F . The single nucleotide polymorphism -1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia. J Mol Med (Berl). 2003; 81(10):645-54. DOI: 10.1007/s00109-003-0465-4. View

20.

Talmud P, Cooper J, Hattori H, Miller I, Miller G, Humphries S . The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II. Diabetologia. 2006; 49(10):2337-40. DOI: 10.1007/s00125-006-0387-0. View